Theorem Clinical Research

Mayo Clinic

Vtesse forms scientific advisory board

Friday, March 27, 2015 01:47 PM

Vtesse, a rare disease company focused on developing drugs for Niemann-Pick Disease Type C (NPC) and other severe diseases with great unmet need, has formed its scientific advisory board (SAB). Comprising experts from a range of fields including pediatrics, translational medicine, biomarker research and genetics, the SAB will advise on clinical and regulatory strategy as well as product development for the company's lead candidate, VTS-270.

More... »

Quest Diagnostics

Mayo Clinic, Gentag to develop wireless sensors for treatment of obesity and diabetes

Thursday, March 5, 2015 12:35 PM

Mayo Clinic, a nonprofit organization based in Rochester, Minn., and Gentag, a wearable biosensor company based in Washington, D.C., have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes.

More... »


Exact Sciences, Mayo Clinic extend, expand collaboration

Monday, February 9, 2015 12:06 PM

Exact Sciences, a Madison, Wis.-based molecular diagnostics company, and Rochester, Minn.-based Mayo Clinic have announced a five-year extension and expansion of their collaboration, broadening their efforts to develop screening, surveillance and diagnostic tests beyond colorectal cancer to address other diseases within the gastrointestinal tract.

More... »

TapImmune reports positive immune responses in phase I cancer trial

Friday, January 16, 2015 01:08 PM

TapImmune, an immunotherapy company, has reported the completion of data analysis from all 21 evaluable patients treated in a phase I clinical trial. In addition, the recent financing provides immediate, short term and long term access to the capital required to execute its exclusive option to license these very promising peptides and to progress its on-going clinical program into phase II trials.

More... »

Optum Labs adds five collaborators

Thursday, January 15, 2015 01:37 PM

Optum Labs, a Cambridge, Mass.-based collaborative research and innovation center co-founded by Optum and Mayo Clinic, has added five new collaborators committed to improving the quality and value of patient care. These include:

More... »

NIH awards $5.9M in grants for frontotemporal degeneration research

Wednesday, October 29, 2014 01:34 PM

The NIH will award three large, five-year projects on a specific form of dementia, known as frontotemporal because of the areas of the brain that are affected. The projects, funded by the NIH's National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Aging (NIA) and the National Center for Advancing Translational Sciences (NCATS), will receive more than $5.9 million for 2014.

More... »

Quest Diagnostics names Franklin R. Cockerill VP, chief laboratory officer

Thursday, October 9, 2014 11:10 AM

Quest Diagnostics, a provider of diagnostic information services, has announced that Franklin R. Cockerill, III, M.D., has joined the company as vice president and chief laboratory officer, effective Oct. 1.

More... »

Second Genome, Mayo Clinic collaborate to develop microbiome therapeutics

Thursday, October 9, 2014 09:00 AM

Second Genome, a South San Francisco, Calif.-based developer of novel medicines through innovative microbiome science, has entered into an extensive partnership with the Minnesota-based Mayo Clinic Center for Individualized Medicine to support the development of therapeutic products for multiple disease indications, starting with inflammatory bowel disease, metabolic disorders and colorectal cancer.

More... »

National MS Society invests nearly $19 million in MS research

Thursday, October 2, 2014 02:16 PM

The National Multiple Sclerosis (MS) Society has committed nearly $19 million to support an expected 54 new MS research projects. These are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost and ending the disease forever.

More... »

Healthcare Leadership Council profiles inVentiv Health

Tuesday, November 26, 2013 10:00 AM

inVentiv Health, a global provider of best-in-class clinical, commercial and consulting services, has announced a cutting-edge inVentiv program for managing the care of chronic kidney disease has been included in a compilation of breakthrough innovations helping transform the American healthcare system.

More... »


CWWeekly

March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs